Researchers at Harvard and its affiliates appreciate that the university resisted the Trump Administration's demands, but ...

Critiques of the vaccine injury reporting system have long been part of Kennedy’s efforts to questions the safety of ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

A small increase in the autism rate suggests diagnosis and access to care are improving, researchers say — and don't herald a ...

Trump's order is designed to reduce health care costs for older adults and people with disabilities, but the path to ...

Researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure — by ...

Join STAT reporters for a virtual recap of ASCO 2025 — highlighting the latest breakthroughs, industry news, and key moments ...

J&J also raised its full-year revenue guidance to include sales of the psychiatric drug Caplyta, which the company got from ...

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to imposing tariffs ...

The head of Mass General Brigham said officials at the Harvard-affiliated health system believe the Trump administration's funding freeze shouldn’t apply to MGB.

Sarah Fortune, Harvard tuberculosis expert, says a Trump administration order could lead to scientist layoffs and the deaths of research monkeys.

In a Phase 3 randomized trial of more than 600 people, an antibiotic pill called gepotidacin (normally used to treat UTIs) was found to be just as effective as the current standard course of treatment ...